
News|Articles|May 1, 2024
Espansione Group: Illuminating the Future of AMD Treatment: The Breakthrough of LightWave I Trial with PBM Technology
Advertisement
Advertorial: Espansione Group: Illuminating the Future of AMD Treatment:
The Breakthrough of LightWave I Trial with PBM Technology
Espansione Group, a global leader in photobiomodulation (PBM), has marked its presence with significant advancements in ophthalmology and beyond. After a decade where it has made significant strides, especially in the anterior segment of the eye, the company is now pioneering its application for the posterior pole, venturing into new territory with treatments for Age-Related Macular Degeneration (AMD), specifically in its early stages (i.e.,dry AMD).
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Safety Considerations in Retinal Vascular Diseases
5






















